This is a Validated Antibody Database (VAD) review about human CDC42BPA, based on 2 published articles (read how Labome selects the articles), using CDC42BPA antibody in all methods. It is aimed to help Labome visitors find the most suited CDC42BPA antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CDC42BPA synonym: MRCK; MRCKA; PK428; serine/threonine-protein kinase MRCK alpha; CDC42 binding protein kinase alpha (DMPK-like); CDC42 binidng protein kinase beta; DMPK-like alpha; MRCK alpha; myotonic dystrophy kinase-related CDC42-binding kinase alpha; myotonic dystrophy kinase-related CDC42-binding protein kinase alpha; myotonic dystrophy protein kinase-like alpha; ser-thr protein kinase PK428; ser-thr protein kinase related to the myotonic dystrophy protein kinase

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (B-3)
  • western blot knockout validation; mouse; loading ...; fig 7f
Santa Cruz Biotechnology CDC42BPA antibody (Santa, sc-374568) was used in western blot knockout validation on mouse samples (fig 7f). J Biol Chem (2018) ncbi
Abnova
mouse monoclonal (1G7)
  • western blot knockout validation; human; loading ...; fig s4a
Abnova CDC42BPA antibody (Abnova, H00008476-M01) was used in western blot knockout validation on human samples (fig s4a). Cancer Res (2018) ncbi
Abnova
mouse monoclonal (1G7)
  • western blot knockout validation; human; loading ...; fig s4a
Abnova CDC42BPA antibody (Abnova, H00008476-M01) was used in western blot knockout validation on human samples (fig s4a). Cancer Res (2018) ncbi
Santa Cruz Biotechnology
mouse monoclonal (B-3)
  • western blot knockout validation; mouse; loading ...; fig 7f
Santa Cruz Biotechnology CDC42BPA antibody (Santa, sc-374568) was used in western blot knockout validation on mouse samples (fig 7f). J Biol Chem (2018) ncbi
Articles Reviewed
  1. Ge J, Burnier L, Adamopoulou M, Kwa M, Schaks M, Rottner K, et al. RhoA, Rac1, and Cdc42 differentially regulate αSMA and collagen I expression in mesenchymal stem cells. J Biol Chem. 2018;293:9358-9369 pubmed publisher
  2. Unbekandt M, Belshaw S, Bower J, Clarke M, Cordes J, Crighton D, et al. Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer. Cancer Res. 2018;78:2096-2114 pubmed publisher